These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9634293)
21. Chromatin control of herpes simplex virus lytic and latent infection. Knipe DM; Cliffe A Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117 [TBL] [Abstract][Full Text] [Related]
22. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756 [TBL] [Abstract][Full Text] [Related]
23. [Present status and task the in study of pathophysiologic mechanism of latent herpes simplex virus infection and the viral re-activation]. Minagawa H Fukuoka Igaku Zasshi; 1995 Jul; 86(7):299-303. PubMed ID: 7665138 [No Abstract] [Full Text] [Related]
24. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience. Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993 [TBL] [Abstract][Full Text] [Related]
25. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed. Schmit I; Boivin G J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview. Annunziata G; Maisto M; Schisano C; Ciampaglia R; Narciso V; Tenore GC; Novellino E Viruses; 2018 Sep; 10(9):. PubMed ID: 30177661 [TBL] [Abstract][Full Text] [Related]
27. The management of herpes simplex virus infections. Yeung-Yue KA; Brentjens MH; Lee PC; Tyring SK Curr Opin Infect Dis; 2002 Apr; 15(2):115-22. PubMed ID: 11964910 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [TBL] [Abstract][Full Text] [Related]
30. Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata. Talarico LB; Zibetti RG; Faria PC; Scolaro LA; Duarte ME; Noseda MD; Pujol CA; Damonte EB Int J Biol Macromol; 2004 Apr; 34(1-2):63-71. PubMed ID: 15178011 [TBL] [Abstract][Full Text] [Related]
31. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Morfin F; Frobert E; Thouvenot D Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384 [TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture. Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844 [TBL] [Abstract][Full Text] [Related]
33. Prediction of activity, synthesis and biological testing of anti-HSV active peptides. Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027 [TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Tyler KL Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091 [TBL] [Abstract][Full Text] [Related]
35. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
36. [Course and treatment of herpervirus hominis infections. II. Therapy]. Luger A Z Haut Geschlechtskr; 1971 Jul; 46(13):399-408. PubMed ID: 4331019 [No Abstract] [Full Text] [Related]
37. Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I). Binns SE; Hudson J; Merali S; Arnason JT Planta Med; 2002 Sep; 68(9):780-3. PubMed ID: 12357386 [TBL] [Abstract][Full Text] [Related]
38. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Epstein JB; Gorsky M; Hancock P; Peters N; Sherlock CH Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):712-6. PubMed ID: 12464896 [TBL] [Abstract][Full Text] [Related]
39. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088 [TBL] [Abstract][Full Text] [Related]
40. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]